NAPOLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 2.339
AS - Asia 937
EU - Europa 842
SA - Sud America 324
AF - Africa 58
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.503
Nazione #
US - Stati Uniti d'America 2.289
SG - Singapore 377
BR - Brasile 263
CN - Cina 259
SE - Svezia 221
IT - Italia 137
RU - Federazione Russa 117
HK - Hong Kong 105
DE - Germania 78
FR - Francia 65
GB - Regno Unito 64
VN - Vietnam 60
FI - Finlandia 54
UA - Ucraina 51
IN - India 29
AR - Argentina 28
MX - Messico 20
CA - Canada 18
ZA - Sudafrica 17
BD - Bangladesh 16
BE - Belgio 13
EC - Ecuador 13
IQ - Iraq 13
ID - Indonesia 12
ET - Etiopia 11
PK - Pakistan 11
CI - Costa d'Avorio 9
ES - Italia 9
TR - Turchia 9
SA - Arabia Saudita 8
NL - Olanda 7
PL - Polonia 7
CO - Colombia 5
DZ - Algeria 5
IE - Irlanda 5
JO - Giordania 5
MA - Marocco 5
PH - Filippine 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
EG - Egitto 4
JP - Giappone 4
AL - Albania 3
AT - Austria 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
PA - Panama 3
GE - Georgia 2
IL - Israele 2
KE - Kenya 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
TH - Thailandia 1
TN - Tunisia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 4.503
Città #
Fairfield 253
Ashburn 245
Chandler 214
Singapore 198
Nyköping 161
Woodbridge 122
San Jose 118
Seattle 107
Jacksonville 106
Houston 105
Hong Kong 104
Ann Arbor 99
Beijing 96
Cambridge 86
Wilmington 81
New York 61
Brooklyn 36
Dallas 34
Lawrence 34
Los Angeles 34
Roxbury 34
Nanjing 32
Lauterbourg 28
Des Moines 27
Helsinki 27
Santa Clara 21
Boardman 20
Ostuni 20
São Paulo 20
Bari 19
Munich 19
Princeton 18
Moscow 17
Frankfurt am Main 15
Hanoi 15
Nanchang 15
Brussels 13
Ho Chi Minh City 13
Johannesburg 13
Addis Ababa 11
Atlanta 10
Inglewood 10
Rio de Janeiro 10
Abidjan 9
Buffalo 9
Chicago 9
Dong Ket 9
Jakarta 9
Rome 9
Baghdad 8
Brasília 8
Hanover 8
London 8
Shenyang 8
Jiaxing 7
Orem 7
Columbus 6
Hebei 6
Paris 6
Poplar 6
San Diego 6
Tianjin 6
Amman 5
Belo Horizonte 5
Denver 5
Dublin 5
Manchester 5
Montreal 5
Porto Alegre 5
Pune 5
Querétaro 5
Riyadh 5
San Francisco 5
Tashkent 5
The Dalles 5
Warsaw 5
Zhengzhou 5
Campinas 4
Changsha 4
Dearborn 4
Dhaka 4
Falkenstein 4
Guangzhou 4
Noci 4
Santo André 4
Taizhou 4
Taranto 4
Tokyo 4
Amsterdam 3
Ankara 3
Belford Roxo 3
Campo Grande 3
Chennai 3
Curitiba 3
Córdoba 3
General Roca 3
Guayaquil 3
Haiphong 3
Joinville 3
Kuala Lumpur 3
Totale 3.020
Nome #
Hepatocellular Carcinoma: Known and Emerging Risk Factors 224
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 211
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 201
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 196
Kikuchi-Fujimoto Disease in an Old Italian Woman: Case Report and Review of the Literature 193
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 173
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 171
Apoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress. 164
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 163
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 163
Sierotipi del virus dell'epatite C e focalità tumorale in pazienti con cirrosi epatica HCV-correlata ed epatocarcinoma 156
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 152
Hepatitis A virus and non-A, non-B virus superinfections in HBsAg chronic carriers. 149
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 144
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes 141
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 140
Impairment of TLR7-dependent signaling in dendritic cells from chronic hepatitis C virus (HCV)-infected non-responders to interferon/ribavirin therapy 136
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 116
Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs 113
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian longitudinal study on aging 112
Manifestazioni extraepatiche multiple in una paziente con epatite cronica C trattata con interferone-alfa 111
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 108
Asymptomatic systemic sarcoidosis arising 5 years after IFN-alfa treatment for chronic hepatitis C: a new challenge for clinicians 107
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 103
Prevalence of antibodies to hepatitis c virus among family members of patients with chronic hepatis c 99
Angiodisplasia gastrica di grave entità in un caso di porpore di Schonlein-Henoch 98
Vasculite sistemica secondaria a trattamento con alfa-interferone in un soggetto con crioglobulinemia mista di tipo II 97
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin 96
Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in Chronic Hepatitis C: a critical reappraisal 95
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 93
Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C 84
Ribavirin and high dose of interferon-alfa for retreatment of patients with chronic hepatitis C resistant to IFN alone 76
Relationship between HCV serotypes and tumor focality in HCV-infected cirrhotic patients with HCC 69
Neutrophil apoptotic cell death: does it contribute to the increased infectious risk in aging? 67
The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response 63
Totale 4.584
Categoria #
all - tutte 16.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 87 33 22
2021/2022315 22 34 1 14 27 54 12 13 16 13 51 58
2022/2023568 79 80 52 52 68 75 3 61 81 5 7 5
2023/2024212 11 36 10 38 15 71 6 8 1 1 3 12
2024/2025786 21 13 61 36 28 68 145 71 28 40 104 171
2025/20261.278 208 61 108 188 186 87 148 36 132 124 0 0
Totale 4.584